Advertisement

Commentary: Pediatric-Antiresorptive Use: Should We Intervene on Third Molars Early?

Published:November 07, 2021DOI:https://doi.org/10.1016/j.joms.2021.09.027
      The recent article by Cimba et al raises an important question that has not been fully answered by the current literature.
      • Cimba MJ
      • Dazen CM
      • Wang S
      • Ford BP.
      Pediatric-antiresorptive use: should we intervene on third molars early?.
      Pediatric patients affected by various skeletal disorders have received antiresorptive medications since around 1998.
      • Glorieux FH
      • Bishop N
      • Plotkin H
      • Chabot G
      • Lanoue G
      • Travers R
      Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.
      Historically, pamidronate has been the treatment of choice with a recent shift to zoledronate. To date, there have been no reported cases of medication related osteonecrosis of the jaws (MRONJ) in the pediatric population. The reason for this has not been fully elucidated.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cimba MJ
        • Dazen CM
        • Wang S
        • Ford BP.
        Pediatric-antiresorptive use: should we intervene on third molars early?.
        J Oral Maxillofac Surg. 2021; 79: 1817-1818
        • Glorieux FH
        • Bishop N
        • Plotkin H
        • Chabot G
        • Lanoue G
        • Travers R
        Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.
        N Engl J Med. 1998; 339: 947-952
        • Ruggiero SL
        • Dodson TB
        • Fantasia J
        • et al.
        American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw−2014 update.
        J Oral Maxillofac Surg. 2014; 72: 1938-1956